newsfilter
← Latest News
Business Wire·

Enanta Pharmaceuticals to Participate in September Investor Conferences

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management